Inventor · disambiguated record
Paolo Martini
Also filed as: MARTINI PAOLO · MARTINI PAOLO G V
26 granted patents·29 pending applications·87 citations·filing 2004–2025
95Inventor score
Files withMODERNATX INC35SHIRE HUMAN GENETIC THERAPIES9MECCANOTECNICA SPA2MODERNA TX INC2SYNAGEVA BIOPHARMA CORP2
Top patents by PatentIndex Score
55 records- 0196US10406112B2Polynucleotides encoding methylmalonyl-CoA mutaseMODERNATX INC·Filed 2018·Granted Sep 10, 2019·7 cites·24 claims
- 0295US11504337B2Polynucleotides encoding methylmalonyl-CoA mutaseMODERNATX INC·Filed 2019·Granted Nov 22, 2022·12 cites·19 claims
- 0395US10426738B2Polynucleotides encoding methylmalonyl-CoA mutaseMODERNATX INC·Filed 2018·Granted Oct 1, 2019·5 cites·29 claims
- 0491US11001861B2Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1MODERNATX INC·Filed 2017·Granted May 11, 2021·11 cites·50 claims
- 0591US10494636B2Polynucleotides encoding α-galactosidase A for the treatment of Fabry diseaseMODERNATX INC·Filed 2018·Granted Dec 3, 2019·3 cites·8 claims
- 0691US9206235B2Peptide linkers for polypeptide compositions and methods for using sameSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Granted Dec 8, 2015·8 cites·22 claims
- 0789US9814764B2Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidaseSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Granted Nov 14, 2017·9 cites·20 claims
- 0889US8580922B2Peptide linkers for polypeptide compositions and methods for using sameMARTINI PAOLO·Filed 2012·Granted Nov 12, 2013·11 cites·12 claims
- 0985US9932568B2Peptide linkers for polypeptide compositions and methods for using sameSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Apr 3, 2018·2 cites·26 claims
- 1084US11649461B2Polynucleotides encoding α-galactosidase A for the treatment of Fabry diseaseMODERNATX INC·Filed 2019·Granted May 16, 2023·1 cites·21 claims
- 1184US10993918B2Polynucleotides encoding citrin for the treatment of Citrullinemia type 2MODERNATX INC·Filed 2017·Granted May 4, 2021·2 cites·50 claims
- 1283US11859215B2Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disordersMODERNATX INC·Filed 2018·Granted Jan 2, 2024·3 cites·29 claims
- 1383US11065307B2Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moietySHIRE HUMAN GENETIC THERAPIES·Filed 2017·Granted Jul 20, 2021·2 cites·8 claims
- 1482US11801227B2Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosisMODERNATX INC·Filed 2017·Granted Oct 31, 2023·1 cites·30 claims
- 1582US2023323371A1Polynucleotides encoding alpha-galactosidase a for the treatment of fabry diseaseMODERNATX INC·Filed 2023·Application pending·0 cites
- 1682US2023270685A1POLYNUCLEOTIDES ENCODING METHYLMALONYL-CoA MUTASEMODERNATX INC·Filed 2022·Application pending·0 cites
- 1781US8945542B2Methods for treating lysosomal acid lipase deficiencySYNAGEVA BIOPHARMA CORP·Filed 2013·Granted Feb 3, 2015·8 cites·3 claims
- 1878US10519455B2Polynucleotides encoding alpha-galactosidase A for the treatment of Fabry diseaseMODERNATX INC·Filed 2018·Granted Dec 31, 2019·1 cites·29 claims
- 1977US2025170070A1Polynucleotides encoding glucose-6-phosphatase for the treatment of glycogen storage diseaseMODERNATX INC·Filed 2024·Application pending·0 cites
- 2075US12377136B2Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyriaMODERNATX INC·Filed 2022·Granted Aug 5, 2025·0 cites·11 claims
- 2175US2024024506A1Polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits for the treatment of propionic acidemiaMODERNATX INC·Filed 2023·Application pending·0 cites
- 2273US2023398074A1Nucleic Acid-Based Therapy of Muscular DystrophiesMODERNATX INC·Filed 2023·Application pending·0 cites
- 2372US2024238210A1Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosisMODERNA TX INC·Filed 2023·Application pending·0 cites
- 2472US2019022019A1POLYNUCLEOTIDES ENCODING METHYLMALONYL-CoA MUTASEMODERNATX INC·Filed 2018·Application pending·0 cites
- 2571US2024247239A1Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disordersMODERNATX INC·Filed 2023·Application pending·0 cites
- 2669US12252704B2Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1MODERNATX INC·Filed 2021·Granted Mar 18, 2025·0 cites·23 claims
- 2768US12239742B2Polynucleotides encoding Citrin for the treatment of Citrullinemia type 2MODERNATX INC·Filed 2021·Granted Mar 4, 2025·0 cites·3 claims
- 2865US2022152225A1Polynucleotides encoding arginase 1 for the treatment of arginase deficiencyMODERNATX INC·Filed 2019·Application pending·0 cites
- 2965US2022401584A1Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndromeMODERNATX INC·Filed 2019·Application pending·0 cites
- 3061US10946687B2Sewing of book blocks without blind stitchMECCANOTECNICA SPA·Filed 2017·Granted Mar 16, 2021·1 cites·27 claims
- 3161US2023009009A1Polynucleotides encoding glucose-6-phosphatase for the treatment of glycogen storage diseaseMODERNATX INC·Filed 2019·Application pending·0 cites
- 3259US2020368162A1Nucleic Acid-Based Therapy of Muscular DystrophiesMODERNATX INC·Filed 2018·Application pending·0 cites
- 3359US2025262320A1Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndromeMODERNA TX INC·Filed 2025·Application pending·0 cites
- 3458US2022265856A1Polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits for the treatment of propionic acidemiaMODERNATX INC·Filed 2018·Application pending·0 cites
- 3555US12485692B2Method and apparatus for sewing book blocks without blind stitch by means of hooksMECCANOTECNICA SPA·Filed 2022·Granted Dec 2, 2025·0 cites·16 claims
- 3654US11059906B2Anti-CCL2 and anti-LOXL2 combination therapy for treatment of sclerodermaSHIRE HUMAN GENETIC THERAPIES·Filed 2014·Granted Jul 13, 2021·0 cites·4 claims
- 3754US2020085916A1Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyriaMODERNATX INC·Filed 2017·Application pending·0 cites
- 3854US2022110966A1Polynucleotides encoding very long-chain acyl-coa dehydrogenase for the treatment of very long-chain acyl-coa dehydrogenase deficiencyMODERNATX INC·Filed 2019·Application pending·0 cites
- 3952US11939601B2Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuriaMODERNATX INC·Filed 2018·Granted Mar 26, 2024·0 cites·19 claims
- 4052US2022133863A1Treatment of sanfilippo syndrome type bSHIRE HUMAN GENETIC THERAPIES·Filed 2021·Application pending·0 cites
- 4151US2015158942A1Anti-ccl2 antibodies for treatment of sclerodermaSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Application pending·0 cites
- 4250US2022243182A1Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex e1-alpha, e1-beta, and e2 subunits for the treatment of maple syrup urine diseaseMODERNATX INC·Filed 2019·Application pending·0 cites
- 4350US2022054653A1Modified mrna for the treatment of progressive familial intrahepatic cholestasis disordersMODERNATX INC·Filed 2019·Application pending·0 cites
- 4450US2018179275A1Anti-ccl2 antibodies for treatment of sclerodermaSHIRE HUMAN GENETIC THERAPIES·Filed 2017·Application pending·0 cites
- 4549US12128113B2Polynucleotides encoding JAGGED1 for the treatment of Alagille syndromeMODERNATX INC·Filed 2017·Granted Oct 29, 2024·0 cites·32 claims
- 4649US2020131498A1Polynucleotides encoding methylmalonyl-coa mutaseMODERNATX INC·Filed 2018·Application pending·0 cites
- 4748US2013330317A1Methods for Treating Lysosomal Acid Lipase DeficiencySYNAGEVA BIOPHARMA CORP·Filed 2013·Application pending·0 cites
- 4845US12123030B2Polynucleotides encoding lipoprotein lipase for the treatment of hyperlipidemiaMODERNATX INC·Filed 2017·Granted Oct 22, 2024·0 cites·55 claims
- 4945US2016289319A1Anti-ccl2 antibodies for treatment of sclerodermaSHIRE HUMAN GENETIC THERAPIES·Filed 2016·Application pending·0 cites
- 5041US2019298657A1Polynucleotides Encoding Acyl-CoA Dehydrogenase, Very Long-Chain for the Treatment of Very Long-Chain Acyl-CoA Dehydrogenase DeficiencyMODERNATX INC·Filed 2017·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →